Vertebral Compression Fracture Devices Market - By Product Type (Balloon Kyphoplasty, Vertebroplasty), Surgery (Minimally Invasive Spine Surgery, Open Spine Surgery), End-use (Hospital, ASCs, Trauma Centers) - Global Forecast 2024 - 2032

Vertebral Compression Fracture Devices Market - By Product Type (Balloon Kyphoplasty, Vertebroplasty), Surgery (Minimally Invasive Spine Surgery, Open Spine Surgery), End-use (Hospital, ASCs, Trauma Centers) - Global Forecast 2024 - 2032

Vertebral Compression Fracture Devices Market size is poised to expand at 7.8% CAGR from 2024 to 2032 driven by the rise in minimally invasive surgeries and technological advancements.

Minimally invasive procedures, such as vertebroplasty and kyphoplasty offer less post-operative pain, quicker recovery, and reduced hospital stays for patients with vertebral fractures. This trend is driving the demand for innovative vertebral compression fracture (VCF) devices as they are designed for precise, safe, and effective treatment. Technological advancements, such as high-viscosity bone cement, advanced imaging modalities, and navigational tools are also enhancing the efficacy and safety of VCF procedures. For instance, in November 2023, ImageBiopsy Lab, an established leader in medical imaging, launched IB Lab FLAMINGO, a deep-learning computer model that can detect vertebral compression fractures in CT scans. With healthcare providers adopting these advanced devices to improve patient outcomes, the market is poised to gain momentum.

The vertebral compression fracture devices industry is segmented into product type, surgery, end-use, and region.

With respect to product type, the market size from the vertebroplasty segment is projected to witness 6.9% CAGR from 2024-2032. Vertebroplasty is a minimally invasive procedure that involves the injection of bone cement into fractured vertebrae to stabilize and alleviate pain. Furthermore, technological advancements are making way for the development of high-viscosity bone cement and navigational tools. The rising prevalence of osteoporosis-related vertebral fractures and the increasing adoption of vertebroplasty for pain management will further propel the segment growth.

In terms of end-use, the vertebral compression fracture devices industry from the ambulatory surgical centers (ASCs) segment generated substantial revenue in 2023 and is poised to record 8.6% growth rate through 2032. ASCs offer efficient and cost-effective alternatives to traditional hospital settings for VCF treatments.. Additionally, the focus of ASCs' on minimally invasive techniques and rapid recovery benefits aligns with the rising demand for VCF treatments. The increasing patient preference for ASCs due to their convenience, shorter wait times, and availability of outpatient procedures including vertebroplasty and kyphoplasty will boost segment growth

Regionally, the Asia Pacific vertebral compression fracture devices industry held a sizable revenue in 2023 and is set to exhibit 8.2% growth rate through 2032 driven by the expanding aging population, which is more susceptible to osteoporosis-related fractures. According to the Asian Federation of Osteoporosis Societies, one-third of Singaporean women aged above 50 years have osteoporosis. Furthermore, studies predict that the overall number of fractures caused by osteoporosis in Singapore will rise from 15,267 in 2017 to 24,104 in 2035, representing a 57.9% spike in less than 20 years. Rising awareness about minimally invasive procedures for vertebral compression fractures, and increasing healthcare expenditure will augment the regional industry outlook.